Brunella Costanza

1.2k total citations
9 papers, 470 citations indexed

About

Brunella Costanza is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Brunella Costanza has authored 9 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Physiology. Recurrent topics in Brunella Costanza's work include TGF-β signaling in diseases (3 papers), Mitochondrial Function and Pathology (2 papers) and Cell Adhesion Molecules Research (2 papers). Brunella Costanza is often cited by papers focused on TGF-β signaling in diseases (3 papers), Mitochondrial Function and Pathology (2 papers) and Cell Adhesion Molecules Research (2 papers). Brunella Costanza collaborates with scholars based in Belgium, France and Italy. Brunella Costanza's co-authors include Vincent Castronovo, Andrei Turtoï, Justine Bellier, Ijeoma Adaku Umelo, Akeila Bellahcène, Olivier Peulen, Philippe Delvenne, Arnaud Blomme, Gilles Rademaker and Elettra Bianchi and has published in prestigious journals such as Oncogene, PLoS Medicine and International Journal of Cancer.

In The Last Decade

Brunella Costanza

9 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brunella Costanza Belgium 8 279 197 156 67 63 9 470
Kelly E. Craven United States 9 233 0.8× 204 1.0× 125 0.8× 61 0.9× 50 0.8× 15 441
Himalaya Parajuli Norway 10 274 1.0× 196 1.0× 136 0.9× 69 1.0× 66 1.0× 17 452
Christin Ungewiss United States 7 305 1.1× 175 0.9× 215 1.4× 56 0.8× 64 1.0× 8 476
Leili Saeednejad Zanjani Iran 13 273 1.0× 201 1.0× 114 0.7× 74 1.1× 75 1.2× 37 497
Anxo Martínez-Ordóñez Spain 10 180 0.6× 193 1.0× 144 0.9× 111 1.7× 37 0.6× 15 434
Natascha Cremers Germany 11 239 0.9× 290 1.5× 137 0.9× 92 1.4× 68 1.1× 12 516
Arulselvi Anbalagan United States 8 222 0.8× 203 1.0× 175 1.1× 45 0.7× 74 1.2× 10 486
Qingnan Wu China 13 257 0.9× 123 0.6× 141 0.9× 74 1.1× 35 0.6× 34 425
Kateřina Bouchalová Czechia 12 193 0.7× 229 1.2× 128 0.8× 41 0.6× 49 0.8× 35 486
Antje Andreas Germany 10 212 0.8× 322 1.6× 212 1.4× 52 0.8× 85 1.3× 16 533

Countries citing papers authored by Brunella Costanza

Since Specialization
Citations

This map shows the geographic impact of Brunella Costanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunella Costanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunella Costanza more than expected).

Fields of papers citing papers by Brunella Costanza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brunella Costanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunella Costanza. The network helps show where Brunella Costanza may publish in the future.

Co-authorship network of co-authors of Brunella Costanza

This figure shows the co-authorship network connecting the top 25 collaborators of Brunella Costanza. A scholar is included among the top collaborators of Brunella Costanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brunella Costanza. Brunella Costanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rademaker, Gilles, Brunella Costanza, Sébastien Pyr dit Ruys, et al.. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis. 11(1). 42–42. 1 indexed citations
2.
Rademaker, Gilles, Brunella Costanza, Sandy Anania, et al.. (2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity through the Control of Oxidative Phosphorylation. Cancers. 11(6). 853–853. 27 indexed citations
3.
Rademaker, Gilles, Brunella Costanza, Justine Bellier, et al.. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. 8(3). 21–21. 23 indexed citations
4.
Costanza, Brunella, Gilles Rademaker, Pascal De Tullio, et al.. (2019). Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. 145(6). 1570–1584. 59 indexed citations
5.
Rademaker, Gilles, Laura Brohée, Marie‐Julie Nokin, et al.. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 37(32). 4398–4412. 49 indexed citations
6.
Umelo, Ijeoma Adaku, Brunella Costanza, & Vincent Castronovo. (2018). Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies. Cancer and Metastasis Reviews. 37(1). 125–145. 15 indexed citations
7.
Costanza, Brunella, Ijeoma Adaku Umelo, Justine Bellier, Vincent Castronovo, & Andrei Turtoï. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. 6(1). 7–7. 136 indexed citations
8.
Blomme, Arnaud, Karim Fahmy, Olivier Peulen, et al.. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. 7(50). 83669–83683. 58 indexed citations
9.
Maris, Pamela, Arnaud Blomme, Brunella Costanza, et al.. (2015). Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine. 12(9). e1001871–e1001871. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026